Stay updated on Psilocybin for Cocaine Use Disorder Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for Cocaine Use Disorder Clinical Trial page.

Latest updates to the Psilocybin for Cocaine Use Disorder Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page now presents the study record for psilocybin-facilitated treatment for cocaine use, including its design, eligibility criteria, outcomes, investigators, and study documents, rather than an error page.SummaryDifference56%

- Check9 days agoChange DetectedThe footer identifies the site as revision v3.8.0 instead of v3.7.2; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study record itself remains inaccessible behind a 403 error.SummaryDifference1%

- Check37 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study page now displays a 403 Forbidden error, indicating access is blocked. This reflects a site accessibility issue rather than an update to the study's content or functionality.SummaryDifference20%

- Check58 days agoChange DetectedRevision: v3.7.0 is now shown on the page, indicating an updated version. The prior Revision: v3.6.6 is removed from the current display.SummaryDifference0.1%

Stay in the know with updates to Psilocybin for Cocaine Use Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for Cocaine Use Disorder Clinical Trial page.